Patents by Inventor SIMON LEEDHAM

SIMON LEEDHAM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Gremlin-1 antagonist for the prevention and treatment of cancer
    Patent number: 12162934
    Abstract: The invention relates to an anti-GREM1 antagonist for use in a method for the treatment or prevention of a cancer.
    Type: Grant
    Filed: June 18, 2019
    Date of Patent: December 10, 2024
    Assignees: UCB BIOPHARMA SRL, OXFORD UNIVERSITY INNOVATION LIMITED, THE UNIVERSITY OF ADELAIDE
    Inventors: Gareth Charles Glyndwr Davies, Simon Leedham, Andrew Zannettino, Kimberley Clark, Duncan Hewett, Vasilios Panagopoulos
  • GREMLIN-1 ANTAGONIST FOR THE PREVENTION AND TREATMENT OF CANCER
    Publication number: 20210253688
    Abstract: The invention relates to an anti-GREM1 antagonist for use in a method for the treatment or prevention of a cancer.
    Type: Application
    Filed: June 18, 2019
    Publication date: August 19, 2021
    Inventors: GARETH CHARLES GLYNDWR DAVIES, SIMON LEEDHAM, ANDREW ZANNETTINO, KIMBERLEY CLARK, DUNCAN HEWETT, VASILIOS PANAGOPOULOS